印度人參 Ashwagandha × 男性睪固酮
結論：證據支持但有警示
證據呈現「初步正面但仍弱」的圖譜：L2 PubMed 系統性回顧（含 2018 SR/MA、2025 SR）顯示 Ashwagandha 在男性可小幅提升睪固酮 10-22%，但試驗數仍少；NCCIH/ODS 與 Cleveland Clinic 同步給出「limited evidence, 2-4 months may increase testosterone」的 cautious 立場；專科指引（AUA、Endocrine Society）完全未將其納入睪固酮缺乏治療選項；Examine 主章節未把 testosterone-male 列為已評級 target condition（僅在 intervention intro 提到 may modestly increase）。
B 🟡 B 初步證據 附警語發布 🚨 high — heavy affiliate marketing in TW community
證據呈現「初步正面但仍弱」的圖譜：L2 PubMed 系統性回顧（含 2018 SR/MA、2025 SR）顯示 Ashwagandha 在男性可小幅提升睪固酮 10-22%，但試驗數仍少；NCCIH/ODS 與 Cleveland Clinic 同步給出「limited evidence, 2-4 months may increase testosterone」的 cautious 立場；專科指引（AUA、Endocrine Society）完全未將其納入睪固酮缺乏治療選項；Examine 主章節未把 testosterone-male 列為已評級 target condition（僅在 intervention intro 提到 may modestly increase）。
整體達不到 B 級的多 RCT、一致性與機轉證據門檻，定位為 C（弱證據／具前景但需更多研究）。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.62
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
87%
證據方向一致性高
證據層級
E2
多篇高品質統合分析（≥2 篇一致）
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.617
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 1 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Examining the Effects of Herbs on Testosterone Concentrations in Men: A Systematic Review
結論：Of 32 studies on 13 herbs, only 9/32 showed statistically significant testosterone increases and just 6/32 were low risk of bias; ashwagandha was one of two herbs (with fenugreek) with positive signal, as 3 of 4 ashwagandha RCTs showed increases (Ambiye 2013 +17.3%, P<0.01; Wankhede 2015 P=0.004; Lopresti 2019 +16.6%) while one Lopresti arm was null.
前往 PubMed Withania somnifera (Indian ginseng) in male infertility: An evidence-based systematic review and meta-analysis
結論：Pooled (mostly observational) data showed improved sperm concentration (MD 13.57 million/ml; 95% CI 11.12-16.01; p<0.00001), motility (MD 8.50%; 95% CI 7.36-9.63; p<0.00001) and volume (MD 0.28 ml; p=0.0004), plus a ~17% rise in serum testosterone after 90 days, but authors conclude the 4 eligible studies (only 1 RCT) are 'too limited' for robust conclusions.
前往 PubMed Effects of Ashwagandha on Reproductive Health: A Systematic Review of Sex-Specific Hormonal and Fertility Outcomes
結論：This qualitative systematic review reports ashwagandha appears to favorably affect male reproductive hormones including testosterone but provides no pooled effect size, CI, or p-value, concluding it is only 'a promising natural adjunct... more study is needed to understand its long-term effects and dosing.'
前往 PubMed A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha in Aging, Overweight Males
結論：Ashwagandha (Shoden, 21 mg withanolide glycosides/day, 8 weeks) produced a 14.7% greater rise in testosterone (p=0.010) and 18% greater rise in DHEA-S (p=0.005) vs placebo, but with NO significant between-group difference in cortisol, estradiol, fatigue, vigor, or sexual well-being.
前往 PubMed Effect of standardized root extract of ashwagandha (Withania somnifera) on well-being and sexual performance in adult males: A randomized controlled trial
結論：Ashwagandha root extract 300 mg twice daily for 8 weeks (n=25/arm) significantly improved subjective sexual well-being and raised serum testosterone by ~66 ng/dL vs placebo (p<0.0001), though testosterone was a secondary endpoint and authors received a clinical-consultation grant from the extract sponsor.
前往 PubMed Withania somnifera and Trigonella foenum-graecum as ingredients of testosterone-boosting supplements: Possible clinical implications
結論：This non-systematic narrative review selected ashwagandha and fenugreek as the two best-documented testosterone-raising herbs and states both 'significantly increase T levels in men' (ashwagandha via inhibiting cortisol/prolactin effects on the HPG axis), but reports no pooled estimate and cautions that small samples, dose/extract heterogeneity, and few trials limit firm conclusions.
前往 PubMed L5a NIH Office of Dietary Supplements
謹慎
ashwagandha extracts may lower stress, anxiety, and cortisol levels 來源↗
L5b Mayo Clinic
中性
— 本適應症無對應資料
L5c Cleveland Clinic
謹慎
There is some limited evidence that suggests that taking ashwagandha for 2 to 4 months may increase testosterone levels and sperm quality. 來源↗
L5d Harvard Health
中性
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
中性
— 本適應症無對應資料
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽
台灣社群（PTT MuscleBeach、Dcard 男性保養）對印度人參提升睪固酮普遍持「謹慎正面」態度，健身族與 30+ 男性常作為輔助補充品，但多數人認為實際感受不明顯、效果因人而異，且常與瑪卡、東哥阿里等放在一起比較。
💬社群實感
意見分歧
破解迷思 社群最常見的 5 個誤解
✓
事實誤以為印度人參是「天然壯陽藥」可立即見效（社群有人指出立即見效的多半摻西藥）
✓
事實誤把印度人參當作睪固酮替代療法（TRT），實際上多數研究只看到睪固酮小幅上升約 15-17%
✓
事實誤以為劑量越高越好，忽略台灣每日 250 mg 上限規定
✓
事實誤以為對所有男性都有效，但研究對象多為壓力大、不孕或睪固酮偏低族群
✓
事實把印度人參、瑪卡、東哥阿里視為同類產品混吃
🩹 社群通報的副作用
- 腸胃不適、腹瀉或噁心（特別是空腹服用）
- 嗜睡、晨起昏沉（睡前服用劑量過高時）
- 少數反映焦慮反彈或情緒平淡
- 甲狀腺亢進者服用後心悸
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- Swanson KSM-66
- Nutricost KSM-66
- Naturecan Fitness KSM-66
- Youtheory KSM-66
- 豐傑生醫（含 Shoden 南非醉茄複方）
- 美國 ARNET 藥廠 ASHWAGANDHA (MENTAL)
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 睪固酮替代治療 (TRT)
- 減重 + 阻力訓練
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-testosterone-male-INT-ashwagandha-001/",
"datePublished": "2026-06-09",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "印度人參能改善男性睪固酮",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}